What is RegenATS?

The addition of autologous thrombin serum (ATS) to Regen PRP physiologically starts the coagulation process and thus enables the production of a leucocyte-reduced platelet gel.

Autologous thrombin serum (ATS) converts soluble fibrinogen to fibrin monomers that polymerise into a clot.

This natural process induces the formation of a three-dimensional fibrin matrix in which the platelets become embedded. This allows for long-lasting growth factor delivery to the treatment site and the matrix serves as a scaffold for new tissue reconstruction.

The coagulation process is a complex cascade of reactions that results in thrombin converting soluble fibrinogen into insoluble fibrin molecules that form the fibrin clot. If calcium is added, this speeds up the process and the fibrin clot is strengthened.

The combination of Regen PRP and RegenATS offers different application possibilities. By adding ATS to the liquid PRP, different viscosities can be achieved. In this way, Regen PRP can be brought into the optimal state and the desired shape for the respective application. The result is a leukocyte-reduced platelet gel (platelets embedded in fibrin matrix), which can also be used as a dimensionally stable membrane, for example. The leucocyte-reduced platelet gel has adhesive properties and falls under the scope of tissue engineering.

Preparation in 3 steps in less than 10 minutes:

Current Progress
Current Progress
Current Progress
Current Progress

Please always read the operating instructions before use:

Intended use of the product:
Preparation of autologous platelet-rich plasma and other plasma-based products.
Class IIb CE certified medical devices
Regen Lab SA is a medical device manufacturer certified to ISO13485 :2016 and MDSAP.

Precautions and warnings:
Sterility must be maintained throughout the phlebotomy procedure. Take adequate precautions to avoid contact with the patient's blood or cross-contamination. Take adequate precautions to protect against needles or broken glass tubes. Do not use any of the sterile components of the kit if the packaging has been opened or damaged. Do not use any component of this kit that is damaged or broken. Do not use the tube if it has lost vacuum. Do not use the sodium citrate or other components of the tube alone. Store between 5ºC and 30ºC; bring the kit to room temperature before use. Do not use after the expiry date.
Disposable; do not reuse any part of the kit. Reuse may cause infection or other illness/injury.
Transfer needles must only be used for fluid transfer or preparation of the injection, but not for the injection itself. Preparation of platelet-rich plasma (PRP) must be performed by or under the supervision of a physician trained in the device and procedures. PRP preparation must only be used by a doctor trained in the procedures. The patient must be informed of general risks and possible adverse effects. The platelet-rich plasma (PRP) must be prepared with fresh blood and used within four hours (product, use as soon as possible and do not store). Dispose of the tubes and other components after use according to the disposal guidelines for potentially contaminated blood products.
Use a centrifuge with swing-out or fixed-angle rotor (e.g. RegenPRP Centri from Regen Lab). Follow the manufacturer's instructions when using the centrifuge. The tubes should be centrifuged at 1500 RZB as described in the instructions for use. High centrifugal forces (greater than 2200 RZB) may cause the tubes to break, come into contact with the blood or possibly cause injury. A lower centrifugal force (less than 1500 RZB) may result in insufficient separation of the blood and contamination of the PRP with red blood cells. The centrifuge inserts should specifically match the size of the tubes. The use of inserts that are too small or too large may cause the tubes to break. Care should be taken to ensure that
the tubes are properly seated in the holder in the centrifuge. The tubes must be balanced in the rotor to avoid possible breakage of the glass.

Injury to blood vessels, haematoma, delayed wound healing and/or infection. Temporary or permanent damage to nerves which may result in pain or numbness. Early or late surgical infection.

prp treatment . Platelet rich plasma treatment . cell therapy regenlab
PRP Supplier prp treatment . Platelet rich plasma treatment . cell therapy regenlab

Dear visitors

The information provided on this website is exclusively reserved to healthcare professionals.

I certify that I am a healthcare professional.